Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Oct 7;10(10):2506. doi: 10.1016/j.jaip.2022.09.001

CME exam: The Regulatory Environment of Telemedicine After COVID-19

PMCID: PMC9537752

Instructions for category 1 Continuing Medical Education credit™.

The American Academy of Allergy, Asthma & Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Test ID no.: jaip247

Contact hours: 1.00

Expiration date: September 30, 2023

AMA PRA Category 1 Credit™ can be earned by reading the text material and taking this CME examination online. For complete instruction, visit the Journal’s Web site at www.jaci-inpractice.org.

Learning objectives

  • 1.

    To see patients via telemedicine while adhering to regulations that are likely to go into effect post pandemic.

  • 2.

    To anticipate new and changed regulations that will affect the ability to use telemedicine.

  • 3.

    To locate relevant resources that describe regulations regarding use of telemedicine.

CME items

Question 1. Changes in the US Health Insurance Portability and Accountability Act (HIPAA) regulations during COVID-19 include which of the following?

  • A.

    Any platform can be used for telemedicine regardless of its HIPAA compliance status.

  • B.

    Inadvertent disclosure of protected health information (PHI) no longer needs to be reported to the U.S. Department of Health and Human Service (HHS) during COVID-19.

  • C.

    HIPAA rules were not changed, however, the Notice of Enforcement Discretion (NED) indicated that infractions would not be penalized.

  • D.

    The HIPAA rules were suspended during COVID-19.

Question 2. Which Medicare and Medicaid policy changed during COVID-19?

  • A.

    Patients could be seen if they live in urban areas, but the patient still needs to be in a medical office.

  • B.

    The distance requirement to be seen by telemedicine was reduced from 50 miles to 10 miles.

  • C.

    The rules were changed so that patients do not need to be established patients to be seen by telemedicine.

  • D.

    The types of service permitted via telemedicine were expanded to include almost any service that would normally occur in person.

Question 3. Which of the following is true regarding a virtual check-in?

  • A.

    It can be used both for new and for established patients.

  • B.

    It can only be used for review of video or still images.

  • C.

    It should be a patient-initiated brief communication.

  • D.

    The service should be related to a visit that occurred in the previous 7 days.

Question 4. Which of the following is true regarding billing for remote Therapeutic Monitoring?

  • A.

    A provider does not need to be present when therapeutic recommendations are made.

  • B.

    Patient data should be collected, monitored, and linked to therapeutic interventions.

  • C.

    Self-reported data cannot be used for remote therapeutic monitoring.

  • D.

    Remote Therapeutic Monitoring can be billed for even if the data are collected 1 day per week.


Articles from The Journal of Allergy and Clinical Immunology. in Practice are provided here courtesy of Elsevier

RESOURCES